SEC Form 4 · accession 0001104659-18-002870

PRA Health Sciences, Inc. · PRAH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive VP & CFO

Period of report

Jan 16, 2018

Accepted (ET)

Jan 18, 2018 · 4:36 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001613859

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 16, 2018	M	67,000	$11.73	A	67,000	D
Common Stock^F2	Jan 16, 2018	S	64,405	$90.26	D	2,595	D
Common Stock^F3	Jan 16, 2018	S	2,595	$90.56	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$11.73	Jan 16, 2018	M	39,374	D	—	Dec 20, 2023	Common Stock	39,374	39,931	D
Stock Option (Right to Buy)^F5	$11.73	Jan 16, 2018	M	27,626	D	—	Dec 20, 2023	Common Stock	27,626	117,669	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $89.54 to $90.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.54 to $90.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4The options vested on September 23, 2017.
F5The options vested on March 2, 2016 upon satisfaction of certain performance criteria.